ASHLEY PEREZ: Open Payments
NPI 1417568791 · LEHIGH ACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 89 payments from 20 companies in 2025. Trend: 2023 $1,784 · 2024 $1,733 · 2025 $1,731
Food & beverage: $1,731
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $361 |
| GlaxoSmithKline, LLC. | 11 | $239 |
| ABBVIE INC. | 10 | $198 |
| AstraZeneca Pharmaceuticals LP | 5 | $152 |
| Amgen Inc. | 11 | $142 |
| Lilly USA, LLC | 6 | $113 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Exact Sciences Corporation | 2 | $56 |
| Abbott Laboratories | 2 | $45 |
Products named: TRELEGY ELLIPTA, Ozempic, BREZTRI, VRAYLAR, JARDIANCE, LEQVIO, Rybelsus, EVENITY.
Industry payments across FL — which companies pay providers there.
